Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Liposarcoma × apatinib × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Stomach Neoplasms 54 Carcinoma, Hepatocellular 39 Carcinoma, Non-Small-Cell Lung 21 Small Cell Lung Carcinoma 18 Ovarian Neoplasms 17 Colorectal Neoplasms 15 Breast Neoplasms 13 Sarcoma 12 Triple Negative Breast Neoplasms 11 Nasopharyngeal Carcinoma 11 Neoplasms 10 Esophageal Squamous Cell Carcinoma 10 Esophageal Neoplasms 9 Cholangiocarcinoma 9 Neoplasm Metastasis 7 Lung Neoplasms 7 Advanced Gastric Cancer 7 Squamous Cell Carcinoma of Head and Neck 6 Recurrence 6 Osteosarcoma 6 Head and Neck Neoplasms 6 Biliary Tract Neoplasms 6 Uterine Cervical Neoplasms 5 Liver Neoplasms 5 Solid Tumor 4 Pancreatic Neoplasms 4 Melanoma 4 Glioma 4 Thyroid Neoplasms 3 NSCLC 3

Interventions

Doxorubicin 20 Trabectedin 10 Radiotherapy 10 Ifosfamide 10 pazopanib 5 Gemcitabine 5 ribociclib 4 Specimen Handling 4 Docetaxel 4 Biopsy 4 selinexor 3 pembrolizumab 3 palbociclib 3 eribulin 3 X-Rays 3 Filgrastim 3 Cyclophosphamide 3 temsirolimus 2 pegfilgrastim 2 liposomal doxorubicin 2 cixutumumab 2 brostallicin 2 brigimadlin 2 belinostat 2 avelumab 2 abemaciclib 2 Vincristine 2 Temozolomide 2 Surgical Procedures, Operative 2 Sunitinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06694324 2024-11-19

First-line Treatment of Advanced/unresectable DDLPS

Fudan University

Phase 2 Not yet recruiting

Liposarcoma, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡